Razes Pharma plant opened in Dushanbe’s Sino district

On 30 October, the President of the Republic of Tajikistan, Leader of the Nation Emomali Rahmon, and the Chairman of the Majlisi Milli of the Majlisi Oli of the Republic of Tajikistan, Chairman of the city of Dushanbe Rustami Emomali, put the limited liability company Razes Pharma plant in the Arbobkhutoni neighbourhood of the capital’s Sino district into operation.

According to the report, this is a joint Tajik-Indian company established in 2022, and implementation of the project under an investment agreement between the Government of the Republic of Tajikistan and Razes Pharma began in May 2024. In the first phase, four production lines have been launched and 100 types of medicines are being produced. The plant’s annual capacity is 1.4 billion tablets, 300 million capsules, 21 million units of liquid medicines for external use, and 13 million units of ointments, creams and gels.

It was also stated that the range of products will be expanded to 250 types in the future. The second phase foresees a new production workshop of more than 10,000 square metres, with investment of more than 150 million somoni and the creation of 150 new jobs.